These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 33479632)

  • 1.
    Liu Y; Chen C; Sun LY; Gao H; Zhen JB; Yang KW
    RSC Med Chem; 2020 Feb; 11(2):259-267. PubMed ID: 33479632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dihydroxyphenyl-substituted thiosemicarbazone: A potent scaffold for the development of metallo-β-lactamases inhibitors and antimicrobial.
    Liu L; Xu YS; Chigan JZ; Zhai L; Ding HH; Wu XR; Chen WY; Yang KW
    Bioorg Chem; 2022 Oct; 127():105928. PubMed ID: 35717802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Azolylthioacetamide: A Highly Promising Scaffold for the Development of Metallo-β-lactamase Inhibitors.
    Yang SK; Kang JS; Oelschlaeger P; Yang KW
    ACS Med Chem Lett; 2015 Apr; 6(4):455-60. PubMed ID: 25893049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dithiocarbamate as a Valuable Scaffold for the Inhibition of Metallo-β-Lactmases.
    Ge Y; Xu LW; Liu Y; Sun LY; Gao H; Li JQ; Yang K
    Biomolecules; 2019 Nov; 9(11):. PubMed ID: 31694268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hydroxamic acid with benzenesulfonamide: An effective scaffold for the development of broad-spectrum metallo-β-lactamase inhibitors.
    Li JQ; Chen C; Yao M; Sun LY; Gao H; Chigan J; Yang KW
    Bioorg Chem; 2020 Dec; 105():104436. PubMed ID: 33171408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rhodanine as a Potent Scaffold for the Development of Broad-Spectrum Metallo-β-lactamase Inhibitors.
    Xiang Y; Chen C; Wang WM; Xu LW; Yang KW; Oelschlaeger P; He Y
    ACS Med Chem Lett; 2018 Apr; 9(4):359-364. PubMed ID: 29670701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amino Acid Thioesters Exhibit Inhibitory Activity against B1-B3 Subclasses of Metallo-β-lactamases.
    Zhang YJ; Liu XL; Wang WM; Chen C; Zhao MH; Yang KW
    Chem Pharm Bull (Tokyo); 2019; 67(2):135-142. PubMed ID: 30713274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Azolylthioacetamides as a potent scaffold for the development of metallo-β-lactamase inhibitors.
    Xiang Y; Chang YN; Ge Y; Kang JS; Zhang YL; Liu XL; Oelschlaeger P; Yang KW
    Bioorg Med Chem Lett; 2017 Dec; 27(23):5225-5229. PubMed ID: 29122480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Halogen-Substituted Triazolethioacetamides as a Potent Skeleton for the Development of Metallo-β-Lactamase Inhibitors.
    Zhang Y; Yan Y; Liang L; Feng J; Wang X; Li L; Yang K
    Molecules; 2019 Mar; 24(6):. PubMed ID: 30934584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amino Acid Thioester Derivatives: A Highly Promising Scaffold for the Development of Metallo-β-lactamase L1 Inhibitors.
    Liu XL; Shi Y; Kang JS; Oelschlaeger P; Yang KW
    ACS Med Chem Lett; 2015 Jun; 6(6):660-4. PubMed ID: 26101570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diaryl-substituted thiosemicarbazone: A potent scaffold for the development of New Delhi metallo-β-lactamase-1 inhibitors.
    Li JQ; Sun LY; Jiang Z; Chen C; Gao H; Chigan JZ; Ding HH; Yang KW
    Bioorg Chem; 2021 Feb; 107():104576. PubMed ID: 33383326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dipyridyl-substituted thiosemicarbazone as a potent broad-spectrum inhibitor of metallo-β-lactamases.
    Li JQ; Gao H; Zhai L; Sun LY; Chen C; Chigan JZ; Ding HH; Yang KW
    Bioorg Med Chem; 2021 May; 38():116128. PubMed ID: 33862468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N-acylhydrazones confer inhibitory efficacy against New Delhi metallo-β-lactamase-1.
    Gao H; Li JQ; Kang PW; Chigan JZ; Wang H; Liu L; Xu YS; Zhai L; Yang KW
    Bioorg Chem; 2021 Sep; 114():105138. PubMed ID: 34229201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-heterocyclic dicarboxylic acids: broad-spectrum inhibitors of metallo-β-lactamases with co-antibacterial effect against antibiotic-resistant bacteria.
    Feng L; Yang KW; Zhou LS; Xiao JM; Yang X; Zhai L; Zhang YL; Crowder MW
    Bioorg Med Chem Lett; 2012 Aug; 22(16):5185-9. PubMed ID: 22796180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quinolinyl sulfonamides and sulphonyl esters exhibit inhibitory efficacy against New Delhi metallo-β-lactamase-1 (NDM-1).
    Chigan JZ; Hu Z; Liu L; Xu YS; Ding HH; Yang KW
    Bioorg Chem; 2022 Mar; 120():105654. PubMed ID: 35149265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carbamylmethyl Mercaptoacetate Thioether: A Novel Scaffold for the Development of L1 Metallo-β-lactamase Inhibitors.
    Chang YN; Xiang Y; Zhang YJ; Wang WM; Chen C; Oelschlaeger P; Yang KW
    ACS Med Chem Lett; 2017 May; 8(5):527-532. PubMed ID: 28523105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The assemblage of covalent and metal binding dual functional scaffold for cross-class metallo-β-lactamases inhibition.
    Chen C; Liu Y; Zhang YJ; Ge Y; Lei JE; Yang KW
    Future Med Chem; 2019 Sep; 11(18):2381-2394. PubMed ID: 31544522
    [No Abstract]   [Full Text] [Related]  

  • 18. X-ray absorption spectroscopy of the zinc-binding sites in the class B2 metallo-beta-lactamase ImiS from Aeromonas veronii bv. sobria.
    Costello AL; Sharma NP; Yang KW; Crowder MW; Tierney DL
    Biochemistry; 2006 Nov; 45(45):13650-8. PubMed ID: 17087519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of hydroxamate as a promising scaffold dually inhibiting metallo- and serine-β-lactamases.
    Wu XR; Chen WY; Liu L; Yang KW
    Eur J Med Chem; 2024 Feb; 265():116055. PubMed ID: 38134748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and Bioactivity of Thiazolethioacetamides as Potential Metallo-β-Lactamase Inhibitors.
    Zhang YL; Yan Y; Wang XJ; Yang KW
    Antibiotics (Basel); 2020 Feb; 9(3):. PubMed ID: 32110966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.